Anika Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q3 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Anika Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q3 2014 to Q2 2024.
  • Anika Therapeutics, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $33.8M, a 8.07% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $33.8M -$2.96M -8.07% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $32.1M +$1.45M +4.73% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $36M +$1.33M +3.85% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $34.7M +$514K +1.5% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $36.7M +$4.57M +14.2% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $30.6M +$1.32M +4.49% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $34.6M +$4.78M +16% Dec 31, 2022 10-K 2024-03-15
Q3 2022 $34.2M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $32.2M +$32.2M Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $29.3M +$29.3M Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $29.8M +$27.3M +1093% Dec 31, 2021 10-K 2023-03-16
Q2 2021 $0 -$27.6M -100% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $0 -$26.5M -100% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $2.5M -$25M -90.9% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $20.5M -$49.3M -70.6% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $27.6M -$44.4M -61.7% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $26.5M -$44.8M -62.9% Mar 31, 2020 10-Q 2020-05-22
Q4 2019 $27.5M -$42.5M -60.7% Dec 31, 2019 10-K/A 2021-04-26
Q3 2019 $69.8M +$2.64M +3.93% Sep 30, 2019 10-Q 2019-10-28
Q2 2019 $72M +$58.8M +444% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 $71.2M +$50M +235% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $70M +$46M +192% Dec 31, 2018 10-K 2020-03-06
Q3 2018 $67.2M +$41.4M +161% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $13.3M -$11.8M -47% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 $21.3M +$2M +10.4% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $24M +$3.5M +17.1% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $25.8M +$3.5M +15.7% Sep 30, 2017 10-Q 2017-10-27
Q2 2017 $25M +$2.5M +11.1% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $19.3M -$3.75M -16.3% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $20.5M -$7.25M -26.1% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $22.3M +$243K +1.1% Sep 30, 2016 10-Q 2016-11-01
Q2 2016 $22.5M +$3.99M +21.5% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 $23M +$10.5M +84% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 $27.8M +$21M +311% Dec 31, 2015 10-K 2017-02-24
Q3 2015 $22M +$2.01M +10% Sep 30, 2015 10-Q 2015-11-03
Q2 2015 $18.5M Jun 30, 2015 10-Q 2015-08-04
Q1 2015 $12.5M Mar 31, 2015 10-Q 2015-05-04
Q4 2014 $6.75M Dec 31, 2014 10-K 2016-03-10
Q3 2014 $20M Sep 30, 2014 10-Q 2014-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.